SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
ALEXION PHARMACEUTICALS
(NQNM:ALXN Last Sale: 103.84 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (ALXN : $103.84)
$23,062,864 million Market Cap at Market Close, July 1, 2022
Biomedics SubIndustry up .00% / Health Industry up .00% Today
352 Knotter Drive Research Report Earnings Snapshot - Last 01/29/19
Cheshire, CT 06410 Fact Sheet
Phone: (203) 272-2596 Financial Statements
Fax: (203) 271-8198 Peer Comparison
Annual Reports

Max Link, Chmn., Leonard Bell, CEO, David Kaiser, Pres./COO, Vikas Simba, CFO
Research and development firm specializing in the development of novel biopharmaceuticals, cells, and tissues. IPO at $8.25 February 27, 1996. Raised $18.2 MM, selling 2.2 MM shares, 31% of the outstanding. Lead Manager: Josephthal. Secondary sold 2.5 million shares at $26.75 August 12, 2005.
Historical Charts    Technical Analysis
No Historical Data available for ALXN

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common ALXN $103.84 $103.84 0 .0 $102.37 $104.3 1,833,355 $102.37 $104.3 222,100,000
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock #############

Split, Dividend and Symbol Change Information
Date Symbol Transaction Dividend Split New Symbol
20-MAY-11 ALXN Split 2 for 1
22-AUG-08 ALXN Split 2 for 1

A156
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex